Work

Comparing an operation to monitoring, with or without endocrine therapy (COMET), for low-risk ductal carcinoma in situ (DCIS).

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.tps616

Authors: Thomas Lynch, Elizabeth S. Frank, Deborah E. Collyar, Donna Pinto, Desiree Basila, Ann H. Partridge, Alastair Mark Thompson, Eun-Sil Shelley Hwang, Fan Li, Yi Ren, Terry Hyslop

Institutions: Duke University, Dana-Farber Cancer Institute, University of California, San Francisco, Baylor College of Medicine, Duke Medical Center, Duke Cancer Institute

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Patient-Centered Outcomes Research Institute

OpenAlex ID: W4281911844

Cites:

Cited by: 2

Related to: 10